Effective pharmacological treatment options for abdominal aortic aneurysm (AAA) are missing. A study by Zhang et al. suggests that targeting the thrombo-inflammatory activity of platelets by blocking the intracellular accumulation of ceramides might limit AAA progression while not affecting hemostatic platelet function.
This is a preview of subscription content, log in via an institution to check access.
References
Golledge, J. Nat. Rev. Cardiol. 16, 225–242 (2019).
Cameron, S. J. et al. Blood 132, 2619–2628 (2018).
Owens, A. P. et al. Arterioscler. Thromb. Vasc. Biol. 35, 2032–2041 (2015).
Lindholt, J. S. et al. Vasc. Endovascular. Surg. 42, 329–334 (2008).
Thompson, A. et al. J. Vasc. Surg. 52, 55–61 (2010).
Stoll, G. & Nieswandt, B. Nat. Rev. Neurol. 15, 473–481 (2019).
Kleinschnitz, C. et al. Circulation 115, 2323–2330 (2007).
Nieswandt, B. et al. J. Physiol. 589, 4115–4123 (2011).
Zhang, X. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-023-00364-1 (2023).
Choi, R. H. et al. Nat. Rev. Cardiol. 18, 701–711 (2021).
Acknowledgements
We thank V. Göb and S. Beck for critical reading of the manuscript, and S. Beck for help with preparation of the figure. The work in our laboratory is continuously funded by the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation), project number 374031971–TRR 240 and project number 453989101–SFB1525.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Nieswandt, B., Vögtle, T. Platelet ceramides drive thrombo-inflammation in aortic aneurysm formation. Nat Cardiovasc Res 2, 1112–1114 (2023). https://doi.org/10.1038/s44161-023-00374-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-023-00374-z
- Springer Nature Limited